Basic Pharmacokinetics of Bisoprolol, a New Highly Beta1‐selective Adrenoceptor Antagonist
- 12 November 1986
- journal article
- research article
- Published by Wiley in The Journal of Clinical Pharmacology
- Vol. 26 (8), 616-621
- https://doi.org/10.1002/j.1552-4604.1986.tb02959.x
Abstract
The basic pharmacokinetics of bisoprolol were investigated in three independent studies involving 23 healthy volunteers. After administering 20 mg of 14C-bisoprolol orally, mean elimination half-lives of 11 hours for the unchanged drug and 12 hours for total radioactivity were observed. The enteral absorption of bisoprolol was nearly complete. Fifty percent of the dose was eliminated renally as unchanged bisoprolol and the other 50% metabolically, with subsequent renal excretion of the metabolites. Less than 2% of the dose was recovered from the feces. Intraindividual comparison of the pharmacokinetic data measured after oral and intravenous administration of 10 mg bisoprolol to 12 subjects yielded an absolute bioavailability of 90%. Total and renal clearance were calculated as 15.6 L/hr and 9.6 L/hr, respectively. The volume of distribution was 226 L. Concomitant food intake did not influence the bioavailability of bisoprolol.This publication has 7 references indexed in Scilit:
- β1-Selectivity of Bisoprolol, a New β-Adrenoceptor Antagonist, in Anesthetized Dogs and Guinea PigsJournal of Cardiovascular Pharmacology, 1984
- BETA-1-SELECTIVITY OF BISOPROLOL, A NEW BETA-ADRENOCEPTOR ANTAGONIST, IN ANESTHETIZED DOGS AND GUINEA-PIGS1984
- Clinical pharmacokinetics of atenolol — A reviewEuropean Journal of Drug Metabolism and Pharmacokinetics, 1982
- Characterization of [3H](+/-)carazolol binding to beta-adrenergic receptors. Application to study of beta-adrenergic receptor subtypes in canine ventricular myocardium and lung.Circulation Research, 1981
- NadololDrugs, 1980
- Clinical Pharmacokinetics of MetoprololClinical Pharmacokinetics, 1980
- Clinical Pharmacokinetics of PropranololClinical Pharmacokinetics, 1979